Michael Cherny
Stock Analyst at Leerink Partners
(3.34)
# 994
Out of 4,711 analysts
124
Total ratings
53.41%
Success rate
1%
Average return
Main Sectors:
Stocks Rated by Michael Cherny
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PDCO Patterson Companies | Downgrades: Market Perform | $29 → $31 | $30.86 | +1.59% | 22 | Dec 11, 2024 | |
| IQV IQVIA Holdings | Reiterates: Outperform | $260 → $248 | $197.27 | +25.72% | 2 | Nov 19, 2024 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | $270 → $255 | $207.51 | +22.89% | 3 | Nov 19, 2024 | |
| PGNY Progyny | Maintains: Buy | $22 → $21 | $14.34 | +46.44% | 9 | Nov 13, 2024 | |
| XRAY DENTSPLY SIRONA | Downgrades: Market Perform | n/a | $18.70 | - | 8 | Nov 7, 2024 | |
| NVST Envista Holdings | Upgrades: Market Perform | $16 → $23 | $18.70 | +22.99% | 10 | Oct 31, 2024 | |
| HIMS Hims & Hers Health | Maintains: Buy | $23 → $25 | $26.20 | -4.58% | 9 | Oct 21, 2024 | |
| MCK McKesson | Maintains: Outperform | $665 → $630 | $579.74 | +8.67% | 10 | Oct 7, 2024 | |
| COR Cencora | Maintains: Outperform | $277 → $275 | $227.69 | +20.78% | 3 | Oct 7, 2024 | |
| CVS CVS Health | Maintains: Buy | $95 → $77 | $44.36 | +73.58% | 10 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $25 | $2.59 | +865.25% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $23 → $22 | $9.55 | +130.37% | 2 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $135 | $153.10 | -11.82% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $125 | $118.28 | +5.68% | 9 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $260 | $228.61 | +13.73% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $23 | $21.76 | +3.40% | 5 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $8 | $4.44 | +80.18% | 5 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $32 | $57.83 | -44.67% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $19 | $10.71 | +77.40% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $310 | $211.06 | +46.88% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $78 | $69.82 | +11.72% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $3.48 | +359.77% | 7 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $17 | $9.44 | +80.08% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $113 → $53 | $12.78 | +310.80% | 2 | Jan 5, 2022 |
Patterson Companies
Dec 11, 2024
Downgrades: Market Perform
Price Target: $29 → $31
Current: $30.86
Upside: +1.59%
IQVIA Holdings
Nov 19, 2024
Reiterates: Outperform
Price Target: $260 → $248
Current: $197.27
Upside: +25.72%
ICON Public Limited Company
Nov 19, 2024
Reiterates: Outperform
Price Target: $270 → $255
Current: $207.51
Upside: +22.89%
Progyny
Nov 13, 2024
Maintains: Buy
Price Target: $22 → $21
Current: $14.34
Upside: +46.44%
DENTSPLY SIRONA
Nov 7, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $18.70
Upside: -
Envista Holdings
Oct 31, 2024
Upgrades: Market Perform
Price Target: $16 → $23
Current: $18.70
Upside: +22.99%
Hims & Hers Health
Oct 21, 2024
Maintains: Buy
Price Target: $23 → $25
Current: $26.20
Upside: -4.58%
McKesson
Oct 7, 2024
Maintains: Outperform
Price Target: $665 → $630
Current: $579.74
Upside: +8.67%
Cencora
Oct 7, 2024
Maintains: Outperform
Price Target: $277 → $275
Current: $227.69
Upside: +20.78%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $95 → $77
Current: $44.36
Upside: +73.58%
Apr 22, 2024
Initiates: Outperform
Price Target: $25
Current: $2.59
Upside: +865.25%
Mar 18, 2024
Maintains: Market Perform
Price Target: $23 → $22
Current: $9.55
Upside: +130.37%
Feb 26, 2024
Initiates: Market Perform
Price Target: $135
Current: $153.10
Upside: -11.82%
Feb 26, 2024
Initiates: Outperform
Price Target: $125
Current: $118.28
Upside: +5.68%
Feb 26, 2024
Initiates: Outperform
Price Target: $260
Current: $228.61
Upside: +13.73%
Feb 26, 2024
Initiates: Market Perform
Price Target: $23
Current: $21.76
Upside: +3.40%
Feb 26, 2024
Initiates: Outperform
Price Target: $8
Current: $4.44
Upside: +80.18%
Feb 26, 2024
Initiates: Market Perform
Price Target: $32
Current: $57.83
Upside: -44.67%
Feb 26, 2024
Initiates: Market Perform
Price Target: $19
Current: $10.71
Upside: +77.40%
Feb 26, 2024
Initiates: Market Perform
Price Target: $310
Current: $211.06
Upside: +46.88%
Feb 26, 2024
Initiates: Market Perform
Price Target: $78
Current: $69.82
Upside: +11.72%
Feb 26, 2024
Initiates: Outperform
Price Target: $16
Current: $3.48
Upside: +359.77%
Feb 26, 2024
Initiates: Market Perform
Price Target: $17
Current: $9.44
Upside: +80.08%
Jan 5, 2022
Downgrades: Underperform
Price Target: $113 → $53
Current: $12.78
Upside: +310.80%